1. Home
  2. XERS vs MVST Comparison

XERS vs MVST Comparison

Compare XERS & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • MVST
  • Stock Information
  • Founded
  • XERS 2005
  • MVST 2006
  • Country
  • XERS United States
  • MVST United States
  • Employees
  • XERS 394
  • MVST N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • MVST Industrial Machinery/Components
  • Sector
  • XERS Health Care
  • MVST Miscellaneous
  • Exchange
  • XERS Nasdaq
  • MVST Nasdaq
  • Market Cap
  • XERS 1.3B
  • MVST 848.0M
  • IPO Year
  • XERS 2018
  • MVST N/A
  • Fundamental
  • Price
  • XERS $7.93
  • MVST $2.66
  • Analyst Decision
  • XERS Strong Buy
  • MVST Strong Buy
  • Analyst Count
  • XERS 7
  • MVST 1
  • Target Price
  • XERS $8.00
  • MVST $6.00
  • AVG Volume (30 Days)
  • XERS 3.5M
  • MVST 8.2M
  • Earning Date
  • XERS 08-07-2025
  • MVST 08-11-2025
  • Dividend Yield
  • XERS N/A
  • MVST N/A
  • EPS Growth
  • XERS N/A
  • MVST N/A
  • EPS
  • XERS N/A
  • MVST N/A
  • Revenue
  • XERS $246,025,000.00
  • MVST $422,605,000.00
  • Revenue This Year
  • XERS $43.89
  • MVST $25.36
  • Revenue Next Year
  • XERS $20.40
  • MVST $30.46
  • P/E Ratio
  • XERS N/A
  • MVST N/A
  • Revenue Growth
  • XERS 35.62
  • MVST 20.84
  • 52 Week Low
  • XERS $2.48
  • MVST $0.15
  • 52 Week High
  • XERS $8.02
  • MVST $4.72
  • Technical
  • Relative Strength Index (RSI)
  • XERS 80.36
  • MVST 43.36
  • Support Level
  • XERS $7.27
  • MVST $2.61
  • Resistance Level
  • XERS $8.02
  • MVST $2.78
  • Average True Range (ATR)
  • XERS 0.32
  • MVST 0.21
  • MACD
  • XERS 0.03
  • MVST 0.02
  • Stochastic Oscillator
  • XERS 93.99
  • MVST 53.30

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About MVST Microvast Holdings Inc.

Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.

Share on Social Networks: